TECHNOLOGY, SCIENCE AND COLLABORATION
For Patients and their Families
Here you will find useful information about clinic, our doctors, booking an appointment…
For Health Professionals
Find out useful information about our doctors, case studies….
Associate Professor Andrew Chang, Dr Thomas Pham, Dr Ran Wan and Dr Thomas Hong will be heading to Cambodia in August 2019 to help restore vision to underprivileged patients.
New technologies are being utilised in the operating theater.
Associate Professor Andrew Chang Recently presented at the Global Retinal Network Program on new developments in retinal research and the multi-disciplinary approach in treating patients with retinal disease.
Do you have dry age-related macular degeneration? You may be eligible to participate in one of our clinical trials. Please contact our research team for more information.
Announces dosing of first patient in OTX-TKI phase 1 clinical trial for the treatment of wet age-related macular degeneration (AMD).
An orange a day keeps the macular degeneration away.Read more
Scientific Journal Publications
2018 Spooner K, Mhlanga C, Hong T, Broadhead GK, Chang A, The Burden of neovacsular age-related macular degeneration:
Treating the untreatable patient: current options for the management of treatment-resistant neovascular age-related macular degeneration.Read more
Acta Ophthalmol. 2014 Dec;92(8):713-23. doi: 10.1111/aos.12463. Epub 2014 Jun 12. Broadhead GK 1 , Hong T, Chang AA.
Intravitreal Ranibizumab for neovascular Age-related macular degeneration in clinical practice: five-year treatment outcomes.Read more
Graefes Arch Clin Exp Ophthalmol. 2015 Aug;253(8):1217-25. doi: 10.1007/s00417-014-2799-8. Epub 2014 Sep 10. Zhu M 1 , Chew